News

APC-100 is an orally available anti-androgenic/anti-inflammatory, signal transduction inhibitor drug. The recently issued patent strengthens company’s patent portfolio for the use of APC-100 in the treatment of early

Revolade, an oral platelet generator is used to treat thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had

The results of the trial suggested that the drug showed improvement in overall survival as comparison to placebo and has also demonstrated reduction in risk of mortality. The

The antisense drug ISIS-PTP1BRx is intended to increase the body’s sensitivity to the natural hormone insulin, helping in better glucose control for patients suffering from type 2 diabetes.

The trial was designed to investigate the tolerability, safety, efficacy and pharmacokinetics of INO-8875 delivered as an eye-drop formulation in patients with primary open-angle glaucoma or ocular hypertension.

Boca’s Hydrocodone Bitartrate and Acetaminophen Oral Solution, 7.5mg / 325mg per 5ml is the generic version of FSC Laboratories’ Hycet Oral Solution. Boca CEO Robert Edwards said they

The company expects to get the European Commission’s marketing authorization approval for the intensive care sedative dexdor in few months. When approved, the drug can be marketed by

X-22 comprises a kit of very low nicotine (VLN) cigarettes made from 22nd Century’s proprietary tobacco. The X-22 therapy protocol allows patients to smoke X-22 cigarettes without restriction

Initially, the partnership will be focused on branded pharmaceutical products for cardiovascular and metabolic diseases. Under the deal, both the parties will offer combined portfolio of drugs for